Tuesday, October 16, 2001
National Academy of Sciences Auditorium
2100 C Street, N.W., Washington, D.C.
RealPlayer is required to listen to the audio presentations. It is available for free download at http://www.real.com/player
9:15 a.m. Introduction: Where Are We, How Did We Get Here and What Are We Concerned About?
David Korn, MD, Senior Vice President for Biomedical and Health Sciences Research, Association of American Medical Colleges
Segment 1: How Big A Problem Is It?
9:45 a.m. How Big Is the Problem?
David Blumenthal, MD, Professor of Medicine and Health Policy, Harvard Medical School
What Is the Impact?
10:05 a.m. On the University and University Environment
Gilbert S. Omenn, MD, PhD, Executive Vice President for Medical Affairs and CEO of the University of Michigan Health System
10:25 a.m. On Science
Thomas S. Bodenheimer, MD, Clinical Professor, Family and Community Medicine, University of California, San Francisco School of Medicine
10:45 a.m. On Industry
Tadataka Yamada, MD, Chairman, Research and Development, Pharmaceuticals, Glaxo SmithKline, Inc.
11:05 a.m. Discussion
Segment 2: What, If Anything, Should We Do about It?
11:25 a.m. The "Group of 10" Universities
Joseph B. Martin, MD, PhD, Dean Faculty of Medicine, Harvard Medical School
11:45 a.m. Public Sector Perspective
Mark L. Rohrbaugh, PhD, JD, Acting Director, Office of Technology Transfer, National Institutes of Health
12:05 p.m. Discussion
12:30 p.m. Closing Remarks and Announcement of the Rhoda G. and Bernard G. Sarnat International Prize in Mental Health
|